ALX Oncology Holdings Inc.
ALXO • NASDAQ • Stock Fundamentals
ALX Oncology Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jason W. Lettmann, with a market cap of $204.5M.
Market Cap$204.5M
Employees74.0
CEOJason W. Lettmann
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 8, 2026 · 1 month 6 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
ALX Oncology Holdings Inc. FAQ
Common questions about ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc. (ALXO) has a market capitalization of $204.5M and trades on NASDAQ.
ALX Oncology Holdings Inc. has approximately 74 employees.